Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.
Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.
复制标题
DOI:
10.1021/cb100253e
复制
发表时间:
2011-05-20
影响因子:
4
通讯作者:
Williams, John C.
中科院分区:
文献类型:
--
作者:
Buettner, Ralf;Corzano, Renzo;Rashid, Rumana;Lin, Jianping;Senthil, Maheswari;Hedvat, Michael;Schroeder, Anne;Mao, Allen;Herrmann, Andreas;Yim, John;Li, Hongzhi;Yuan, Yate-Ching;Yakushijin, Kenichi;Yakushijin, Fumiko;Vaidehi, Nagarajan;Moore, Roger;Gugiu, Gabriel;Lee, Terry D.;Yip, Richard;Chen, Yuan;Jove, Richard;Horne, David;Williams, John C.
Stat3 is a latent transcription factor that promotes cell survival and proliferation and is often constitutively active in multiple cancers. Inhibition of Stat3 signaling pathways suppresses cell survival signals and leads to apoptosis in cancer cells, suggesting direct inhibition of Stat3 function is a viable therapeutic approach. Herein, we identify a small molecule, C48, as a selective Stat3-family member inhibitor. To determine its mechanism of action, we used site-directed mutagenesis and multiple biochemical techniques to show that C48 alkylates Cys468 in Stat3, a residue at the DNA-binding interface. We further demonstrate that C48 blocks accumulation of activated Stat3 in the nucleus in tumor cell lines that over-express active Stat3 leading to impressive inhibition of tumor growth in mouse models. Collectively, these findings suggest Cys468 in Stat3 represents a novel site for therapeutic intervention and demonstrates the promise of alkylation as a potentially effective chemical approach for Stat3-dependent cancers.
登录
查看更多内容
影响因子:
4.4
作者:
Hintzen, Christoph;Haan, Claude;Hermanns, Heike M.
通讯作者:
Hermanns, Heike M.
影响因子:
56.9
作者:
CONNOLLY, ML
通讯作者:
CONNOLLY, ML
影响因子:
4.8
作者:
Pranada, AL;Metz, S;Müller-Newen, G
通讯作者:
Müller-Newen, G
影响因子:
--
作者:
Hong, Yanyan;Yu, Bin;Chen, Shiuan
通讯作者:
Chen, Shiuan
影响因子:
56.9
作者:
Darnell, JE
通讯作者:
Darnell, JE